Therefore, we hypothesized that harmine might be a sensitizer of AZD9291 in EGFR wild‐type NSCLC treatment by suppressing the STAT3/EGFR/Met pathway. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.